Thibaut Mongon on capital allocation
From Kenvue (NYSE: KVUE) - Q4 2023 Earnings Call · · Business Presentations
“We utilized our strong free cash flow to initiate our dividend program, delivering on our commitment of returning cash to shareholders.”
On , Thibaut Mongon, Former Chief Executive Officer & Director at Kenvue Inc., spoke about capital allocation during Kenvue (NYSE: KVUE) - Q4 2023 Earnings Call on Business Presentations.
About Thibaut Mongon
Thibaut Mongon, as CEO of Kenvue, has discussed the company’s performance and strategy following its spin-off from Johnson & Johnson in May 2023. In earnings calls and media appearances, Mongon described 2023 as a “transformational” year and highlighted the company’s financial results, including $4 billion in revenue and 7.7% organic growth in the second quarter, which he called one of the strongest quarters in the company’s history. He noted that the company maintained its guidance for the full year but tightened the range to reflect a softer start to the cold and flu season. Mongon also addressed a class action lawsuit related to the efficacy of a product, stating that the company saw no impact to the business and that the FDA had not made any determination on the matter. Mongon outlined three key priorities for 2024: reaching more consumers by focusing on 15 priority brands, freeing up resources to invest in those brands, and fostering a culture that rewards performance and impact. He acknowledged challenges in the U.S. skin health and beauty segment, particularly with the Neutrogena brand, and said that restoring its growth was a priority. Mongon also discussed the company’s employee well-being initiatives, including a global employee assistance program and a “global care day” for employees. He expressed confidence in the company’s business model and portfolio, stating that Kenvue was focused on fundamentals and building a strong foundation as an independent company.